not advice and assumptions were made that may be inaccurate
ASX Code Company Mkt Cap Ratio (mkt cap / revenue) 03/2019 Quarterly Revenue from 4C 12/2018 1 AGH ALTHEA 23.4 28.54 $82 2 BDA BOD AUSTRALIA 31.9 4.53 $704 3 ZLD ZELDA THERAPEUTICS 41.0 $0 4 MXC MGC PHARMA 51.0 6.85 $744 5 CPH CRESO PHARMA 55.0 25.11 $219 6 MDC MEDLAB CLINICAL 87.0 6.86 $1,269 7 AC8 AUSCANN 188.0 $0 8 CAN CANN GROUP 297.0 $1 9 EXL ELIXINOL 411.0 3.63 $11,334
Ann: Medlab to Expand Nutraceutical Range into 2,100 Pharmacies, page-6
Add MDC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| MDC (ASX) Chart |
Day chart unavailable
